2019
Pioneers in Dermatology and Venereology: an interview with Prof. Irwin Braverman
Braverman I. Pioneers in Dermatology and Venereology: an interview with Prof. Irwin Braverman. Journal Of The European Academy Of Dermatology And Venereology 2019, 33: 2223-2224. PMID: 31779038, DOI: 10.1111/jdv.16040.Peer-Reviewed Original ResearchThe Dermal Microvascular Unit: Relationship to Immunological Processes and Dermal Dendrocytes
Braverman I. The Dermal Microvascular Unit: Relationship to Immunological Processes and Dermal Dendrocytes. 2019, 91-115. DOI: 10.1201/9780429261893-6.Peer-Reviewed Original Research
2013
Aaron Bunsen Lerner
Braverman I. Aaron Bunsen Lerner. 2013, 664-668. DOI: 10.1007/978-3-642-33224-1_111.Peer-Reviewed Original Research
2009
Did Akhenaten Have the Antley–Bixler Syndrome?
Braverman I. Did Akhenaten Have the Antley–Bixler Syndrome? Annals Of Internal Medicine 2009, 151: 892. DOI: 10.7326/0003-4819-151-12-200912150-00013.Peer-Reviewed Original Research
2008
Aaron Bunsen Lerner (1920–2007)
Braverman I. Aaron Bunsen Lerner (1920–2007). 2008, 620-624. DOI: 10.1007/978-3-540-34093-5_104.Peer-Reviewed Original Research
2006
Art
Braverman I. Art. JAMA 2006, 295: 1840-1845. DOI: 10.1001/jama.295.15.1840.Peer-Reviewed Original Research
2003
Medicine and Art
Braverman I. Medicine and Art. JAMA 2003, 290: 2739-2740. DOI: 10.1001/jama.290.20.2739.Peer-Reviewed Original ResearchCutaneous Complications of Type 1 Diabetes
Bolognia J, Braverman I. Cutaneous Complications of Type 1 Diabetes. 2003, 0: 485-500. DOI: 10.1385/1-59259-310-0:485.Chapters
2000
The Cutaneous Microcirculation
Braverman I. The Cutaneous Microcirculation. Journal Of Investigative Dermatology Symposium Proceedings 2000, 5: 3-9. PMID: 11147672, DOI: 10.1046/j.1087-0024.2000.00010.x.Peer-Reviewed Original ResearchConceptsLaser Doppler flowmetryDermal-subcutaneous junctionRed cell fluxDoppler flowmetryCutaneous microcirculationAscending arteriolesMicrovascular segmentsCell fluxHorizontal plexusLight microscopic featuresSmooth muscle cellsUpper horizontal plexusNormal physiologic stateRed blood cellsPapillary loopsPathogenetic mechanismsSkin biopsiesMicrovascular elementsSkin circulationSkin disordersMuscle cellsRetrograde flowArteriolesFlowmetryBlood cells
1999
Skin Signs of Systemic Disease
Braverman I. Skin Signs of Systemic Disease. Journal Of The American Academy Of Dermatology 1999, 40: 786-787. DOI: 10.1016/s0190-9622(99)70171-4.Peer-Reviewed Original ResearchProtective effects of erythema nodosum in coccidioidomycosis
Braverman I. Protective effects of erythema nodosum in coccidioidomycosis. The Lancet 1999, 353: 168. PMID: 9923870, DOI: 10.1016/s0140-6736(05)77213-5.Peer-Reviewed Original ResearchBiliary Tract Obstruction Secondary to Mycosis Fungoides: A Case Report
Madsen J, Tallini G, Glusac E, Salem R, Braverman I, Robert M. Biliary Tract Obstruction Secondary to Mycosis Fungoides: A Case Report. Journal Of Clinical Gastroenterology 1999, 28: 56-60. PMID: 9916670, DOI: 10.1097/00004836-199901000-00015.Peer-Reviewed Original ResearchConceptsExtrahepatic biliary treeMycosis fungoidesBiliary treeObstructive jaundiceCutaneous T-cell lymphomaMonoclonal T-cell populationMixed lymphocytic infiltratePrevious skin biopsiesBiliary tract obstructionT cell populationsT-cell lymphomaGene rearrangement studiesObstructive symptomsTract obstructionLiver involvementSurgical resectionIsolated involvementLymphocytic infiltrateEndoscopic examinationExtrahepatic ductsAtypical cellsCase reportSkin biopsiesFungoidesMultiple organs
1998
PURPLE (oops! Atrophie blanche) revisited.
Milstone L, Braverman I. PURPLE (oops! Atrophie blanche) revisited. JAMA Dermatology 1998, 134: 1634. PMID: 9875208, DOI: 10.1001/archderm.134.12.1634.Commentaries, Editorials and Letters
1997
The Cutaneous Microcirculation: Ultrastructure and Microanatomical Organization
Braverman I. The Cutaneous Microcirculation: Ultrastructure and Microanatomical Organization. Microcirculation 1997, 4: 329-340. PMID: 9329009, DOI: 10.3109/10739689709146797.Peer-Reviewed Original ResearchConceptsLaser Doppler flowmetryDermal-subcutaneous junctionRed cell fluxCutaneous microcirculationAscending arteriolesMicrovascular segmentsSkin biopsy specimensCell fluxHorizontal plexusLight microscopic featuresSmooth muscle cellsUpper horizontal plexusNormal physiological stateRed blood cellsPapillary loopsBiopsy specimensPathogenetic mechanismsDoppler flowmetryMicrovascular elementsSkin circulationSkin disordersAbility of LDFMuscle cellsRetrograde flowArteriolesTotal skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)
Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDisease-free survivalT2 patientsCrude relapse rateAdjuvant therapyOverall survivalElectron beam therapyRelapse rateEntire cohortMedian disease-free survivalCutaneous T-cell lymphomaBeam therapySalvage of recurrencesAdjuvant systemic therapyEarly-stage patientsManagement of patientsT-cell lymphomaTopical nitrogen mustardDays/weekCombination of therapiesGy/dayTreatments/weekPUVA patientsMedian followSalvage therapy
1996
Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma
Wilson L, Quiros P, Kolenik S, Heald P, Braverman I, Edelson R, Kacinski B. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. Journal Of The American Academy Of Dermatology 1996, 35: 69-73. PMID: 8682967, DOI: 10.1016/s0190-9622(96)90499-5.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyCutaneous T-cell lymphomaRecurrent cutaneous T-cell lymphomaComplete responseT-cell lymphomaElectron beam therapySecond courseMedian disease-free intervalThird courseAdditional coursesBeam therapyDisease-free intervalTreatment of patientsAcceptable risk profileForm of therapyMedian doseMedian survivalMild erythemaPatientsInitial courseTherapyVariety of modalitiesRisk profileEntire groupLocalized radiationRegional vs Systemic Responses to Mental Stress: A Potential Mechanism for Non-Demand-Related Ischemia
Silverman D, Jotkowitz A, Gutter V, Braverman I, O'Connor T. Regional vs Systemic Responses to Mental Stress: A Potential Mechanism for Non-Demand-Related Ischemia. Microvascular Research 1996, 51: 396-399. PMID: 8992237, DOI: 10.1006/mvre.1996.0036.Peer-Reviewed Original Research2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL)
Quiros P, Kacinski B, Heald P, Edelson R, Braverman I, Wilson L. 2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL). International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 355. DOI: 10.1016/s0360-3016(97)85733-1.Peer-Reviewed Original Research
1995
Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy
Wilson L, Licata A, Braverman I, Edelson R, Heald P, Feldman A, Kacinski B. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 987-995. PMID: 7607973, DOI: 10.1016/0360-3016(95)00073-8.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDoxorubicin/cyclophosphamideCutaneous T-cell lymphoma patientsAdjuvant doxorubicin/cyclophosphamideT-cell lymphoma patientsExtracorporeal photochemotherapyComplete responseOverall survivalAdjuvant therapyElectron beam therapyAdjuvant regimenFree survivalCTCL patientsLymphoma patientsBeam therapyAddition of chemotherapyAdvanced stage CTCLClinical complete responseSystemic adjuvant therapyGood partial responseSignificant survival benefitBetter overall survivalRelapse-free survivalSoles of feetNontoxic regimenThe Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide(∗)
Sessa W, Garca-Cardea G, Liu J, Keh A, Pollock J, Bradley J, Thiru S, Braverman I, Desai K. The Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide(∗). Journal Of Biological Chemistry 1995, 270: 17641-17644. PMID: 7543089, DOI: 10.1074/jbc.270.30.17641.Peer-Reviewed Original ResearchConceptsHEK-293 cellsHeterologous expression systemEndothelial nitric oxide synthaseNovel GolgiGolgi associationExpression systemIntracellular signalsCultured endothelial cellsGolgiIntact blood vesselsEnzymeParticulate enzymeProteinEndothelial cellsCellsSynthaseNitric oxide synthaseOxide synthaseBlood vesselsCompartmentalizationNitric oxideTarget